Your browser doesn't support javascript.
loading
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.
He, Li-Na; Chen, Tao; Fu, Sha; Jiang, Yongluo; Zhang, Xuanye; Chen, Chen; Du, Wei; Luo, Linfeng; Li, Anlin; Wang, Yixing; Yu, Hui; Zhou, Yixin; Wang, Yuhong; Yang, Yunpeng; Huang, Yan; Zhao, Hongyun; Fang, Wenfeng; Zhang, Li; Hong, Shaodong.
Afiliación
  • He LN; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Chen T; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Fu S; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Jiang Y; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhang X; Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen C; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation of Sun Yat-sen University; Department of Cellular & Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Du W; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Luo L; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Li A; Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang Y; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Yu H; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhou Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang Y; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Yang Y; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Huang Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhao H; State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Fang W; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhang L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hong S; State Key Laboratory of Oncology in South China, Guangzhou, China.
Ther Adv Med Oncol ; 15: 17588359231200463, 2023.
Article en En | MEDLINE | ID: mdl-37881238
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido